Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance - Yu, H A; Suzawa, K; Jordan, E (Clin Cancer Res, 2018)
, et al.